Submitted by admin on September 25, 2024 - 12:16pm
Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA
BioAge Labs aims to raise $180M from IPO, private placement to fund obesity trials
Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3
Sanofi reportedly gets PE bids for consumer health unit
*please scroll down for all the latest news*
